Early Platelet-Collagen Interactions in Whole Blood and Their Modifications by Aspirin and Dipyridamole Evaluated by a New Method (Basic Wave)
暂无分享,去创建一个
[1] H. Holmsen,et al. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects. , 1984, The Journal of laboratory and clinical medicine.
[2] C. Zoja,et al. Dipyridamole Inhibits Platelet Aggregation in Whole Blood , 1983, Thrombosis and Haemostasis.
[3] Edward Hornby,et al. 1-O-Hexadecyl-2-Acetyl-SN-3-Glycerophosphoryl- choline (PAF): Some Effects on the Aggregation of Human Platelets by Thrombin or Collagen , 1983, Thrombosis and Haemostasis.
[4] J. Barbenel,et al. Platelet aggregation studies in whole human blood. , 1983, Thrombosis research.
[5] H. V. Stel,et al. Binding and inactivation of prostacyclin (PGI2) by human erythrocytes , 1983, British journal of haematology.
[6] J. Vermylen,et al. Prostacyclin production in whole blood throughout normal pregnancy. , 1983, Clinical and experimental hypertension. Part B, Hypertension in pregnancy.
[7] B. Vargaftig,et al. Platelet-activating factor today , 1983 .
[8] S. Heptinstall,et al. Platelet Aggregation in Whole Blood Determined Using the Ultra-Flo 100 Platelet Counter , 1982, Thrombosis and Haemostasis.
[9] F. ten Hoor,et al. Fish oil feeding lowers thromboxane- and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin I3. , 1981, Prostaglandins.
[10] B. Weksler,et al. Prostaglandins: interactions with platelets and polymorphonuclear leukocytes in hemostasis and inflammation. , 1980, The American journal of medicine.
[11] D C Cardinal,et al. The electronic aggregometer: a novel device for assessing platelet behavior in blood. , 1980, Journal of pharmacological methods.
[12] G. Born,et al. Inhibition of platelet thrombus formation by chlorpromazine acting to diminish haemolysis , 1979, Nature.
[13] G. J. Blackwell,et al. Prostacyclin is produced in whole blood [proceedings]. , 1978, British journal of pharmacology.
[14] M. Packham. Methods for Detection of Hypersensitive Platelets , 1978, Thrombosis and Haemostasis.
[15] K. Schmid,et al. Binding of dipyridamole to human platelets and to alpha1 acid glycoprotein and its significance for the inhibition of adenosine uptake. , 1977, The Journal of clinical investigation.
[16] H. Baumgartner. Platelet Interaction with Collagen Fibrils in Flowing Blood , 1977, Thrombosis and Haemostasis.
[17] G. Born,et al. Evidence for inhibition of platelet activation in blood by a drug effect on erythrocytes , 1976, Nature.
[18] R. Haslam,et al. Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine. , 1972, Life sciences. Pt. 2: Biochemistry, general and molecular biology.
[19] P. Henson,et al. LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS THE ROLE OF IGE, BASOPHILS, AND A PLATELET-ACTIVATING FACTOR , 1972 .
[20] H. Roos,et al. Kinetics of adenosine uptake by erythrocytes, and the influence of dipyridamole. , 1972, Molecular pharmacology.
[21] J. Smith,et al. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets. , 1971, The Biochemical journal.
[22] G. Born,et al. Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.